These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16721715)

  • 21. SA experts comment on clopidogrel and aspirin (dual platelet therapy) use with bare metal and drug-eluting stents.
    Cardiovasc J Afr; 2008; 19(1):58. PubMed ID: 18320095
    [No Abstract]   [Full Text] [Related]  

  • 22. Late in-stent thrombosis in a patient with systemic lupus erythematosus and hyperhomocysteinemia while on clopidogrel and aspirin.
    Olivier AC; Hollman JL
    J Invasive Cardiol; 2006 Jun; 18(6):E185-7. PubMed ID: 16775899
    [No Abstract]   [Full Text] [Related]  

  • 23. [Must platelet aggregation inhibitors be discontinued before surgery?].
    Schieber M; Sechtem U
    Dtsch Med Wochenschr; 2004 Feb; 129(6):276. PubMed ID: 14750057
    [No Abstract]   [Full Text] [Related]  

  • 24. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
    MMW Fortschr Med; 2008 Oct; 150(42):52-3. PubMed ID: 18983063
    [No Abstract]   [Full Text] [Related]  

  • 25. Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology.
    Kuliczkowski W; Witkowski A; Polonski L; Watala C; Filipiak K; Budaj A; Golanski J; Sitkiewicz D; Pregowski J; Gorski J; Zembala M; Opolski G; Huber K; Arnesen H; Kristensen SD; De Caterina R
    Eur Heart J; 2009 Feb; 30(4):426-35. PubMed ID: 19174428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.
    Buonamici P; Marcucci R; Migliorini A; Gensini GF; Santini A; Paniccia R; Moschi G; Gori AM; Abbate R; Antoniucci D
    J Am Coll Cardiol; 2007 Jun; 49(24):2312-7. PubMed ID: 17572245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and causes of new-onset dyspnea in 3,719 patients treated with clopidogrel and aspirin combination after coronary stenting.
    Serebruany V; Pokov I; Kuliczkowski W; Vahabi J; Atar D
    Thromb Haemost; 2008 Aug; 100(2):314-8. PubMed ID: 18690353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Secondary cardiovascular prevention: convincing evidence concerning clopidogrel].
    Nervenarzt; 1998 Jul; 69(7 Suppl Uberzeugen):1-4. PubMed ID: 9710880
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
    Karnicki K; Leadley RJ; Baxi S; Peterson T; Wysokinski W; McBane RD
    Thromb Haemost; 2008 Apr; 99(4):759-66. PubMed ID: 18392334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Resistance to desaggregants: causes, clinical implication, methods of diagnosis and correction].
    Kremneva LV; Shalaev SV
    Ter Arkh; 2008; 80(12):89-95. PubMed ID: 19227916
    [No Abstract]   [Full Text] [Related]  

  • 31. [Risk improves effectiveness. Proper administration of platelet aggregation inhibitors].
    Haberl R
    MMW Fortschr Med; 2002 Mar; 144(11):10. PubMed ID: 12066502
    [No Abstract]   [Full Text] [Related]  

  • 32. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
    Gurbel PA
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability of response to antiplatelet therapy: what should we do next?
    Shantsila E; Lip GY
    Fundam Clin Pharmacol; 2009 Feb; 23(1):19-22. PubMed ID: 19267768
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelets and stents.
    Nemergut EC; Shaffrey ME
    J Neurosurg; 2007 Oct; 107(4):900-2; author reply 902. PubMed ID: 17937245
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
    Helft G; Gilard M; Le Feuvre C; Zaman AG
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which patients receiving warfarin can be treated safely with a drug-eluting stent?
    Ryding AD; Banning AP
    Heart; 2008 Mar; 94(3):275-7. PubMed ID: 18276815
    [No Abstract]   [Full Text] [Related]  

  • 37. ACP journal club. Dual antiplatelets for 30 mo after drug-eluting stents reduced stent thrombosis and CV and cerebrovascular events.
    Spencer FA; Guyatt G
    Ann Intern Med; 2015 Mar; 162(6):JC9. PubMed ID: 25775352
    [No Abstract]   [Full Text] [Related]  

  • 38. Coronary artery stenting in patients treated by clopidogrel without aspirin.
    Rott D; Leibowitz D; Amit G; Zahger D; Weiss AT
    Int J Cardiol; 2009 Apr; 133(2):279-81. PubMed ID: 18178268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.
    Pecot CV; Fuller M; Muldowney JA; Misra S
    Tenn Med; 2009 May; 102(5):37-9. PubMed ID: 19456028
    [No Abstract]   [Full Text] [Related]  

  • 40. [Coronary heart disease patient does not tolerate acetylsalicylic acid. Can clopidogrel be prescribed?].
    Rupprecht HJ
    MMW Fortschr Med; 2007 Apr; 149(14):19. PubMed ID: 17668757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.